News

Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that ...
For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...
Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...
Optum and Illumina Inc. researchers documented that less than half of patients with newly diagnosed advanced cancers received ...
Charlotte Coles, chief investigator of the Import Low study, said the trial had "transformed" how early breast cancer is ...
Dipika Kakkar will soon begin targeted therapy—a part of her liver cancer treatment—a month after she underwent surgery for ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...
A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...
Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...
Understanding the gut-brain axis is key to addressing eating disorders. This study highlights microbiota's influence and ...
Prior to the Uveitis (Sycamore) Study, there were few evidence-based therapies for children with moderate to severe uveitis, leading to many suffering serious visual complications and often blindness.